Eleusis is a clinical-stage life science company that has two lines of business: a traditional drug development arm called Eleusis Therapeutics, and a care delivery platform called Eleusis Health Solutions. Here to discuss the company and the potential and power of psychedelic medicine in treating chronic inflammatory disease, mental health, and Alzheimer’s is CEO, founder, and chairman, Shlomi Raz.
Shlomi Raz, CEO, founder and chairman of Eleusis, oversees the company’s corporate and clinical development efforts. Prior to founding Eleusis, Shlomi was a Managing Director at Goldman Sachs, as well as began his corporate career at JPMorgan. He holds an MA from New York University and a BS from Georgetown University.